An Aortic Aneurysm is an enlargement (dilatation) of the aorta to greater than 1.5 times normal size.[1] They usually cause no symptoms except when ruptured.[2] Occasionally, there may be abdominal, back, or leg pain.[3] They are most commonly located in the abdominal aorta, but can also be located in the thoracic aorta. Aortic Aneurysms cause weakness in the wall of the aorta and increase the risk of aortic rupture. When rupture occurs, massive internal bleeding results and, unless treated immediately, shock and death can occur. Screening with ultrasound is indicated in those at high risk. Prevention is by decreasing risk factors, such as smoking, and treatment is either by open or endovascular surgery. Aortic Aneurysms resulted in about 152,000 deaths worldwide in 2013, up from 100,000 in 1990.[4] Aortic Aneurysms are classified by their location on the aorta. Most intact Aortic Aneurysms do not produce symptoms. As they enlarge, symptoms such as abdominal pain and back pain may develop. Compression of nerve roots may cause leg pain or numbness. Untreated, aneurysms tend to become progressively larger, although the rate of enlargement is unpredictable for any individual. Rarely, clotted blood which lines most Aortic Aneurysms can break off and result in an embolus. Aneurysms can be found on physical examination. Medical imaging is necessary to confirm the diagnosis and to determine the anatomic extent of the aneurysm. In patients presenting with aneurysm of the arch of the aorta, a common sign is a hoarse voice from stretching of the left recurrent laryngeal nerve, a branch of the vagus nerve that winds around the aortic arch to supply the muscles of the larynx. Abdominal Aortic Aneurysms (AAAs) are more common than their thoracic counterpart. One reason for this is that elastin, the principal load-bearing protein present in the wall of the aorta, is reduced in the abdominal aorta as compared to the thoracic aorta. Another is that the abdominal aorta does not possess vasa vasorum, the nutrient-supplying blood vessels within the wall of the aorta. Most AAA are true aneurysms that involve all three layers (tunica intima, tunica media and tunica adventitia). The prevalence of AAAs increases with age, with an average age of 65–70 at the time of diagnosis. AAAs have been attributed to atherosclerosis, though other factors are involved in their formation. The risk of rupture of an AAA is related to its diameter; once the aneurysm reaches about 5 cm, the yearly risk of rupture may exceed the risks of surgical repair for an average-risk patient. Rupture risk is also related to shape; so-called "fusiform" (long) aneurysms are considered less rupture prone than "saccular" (shorter, bulbous) aneurysms, the latter having more wall tension in a particular location in the aneurysm wall. Before rupture, an AAA may present as a large, pulsatile mass above the umbilicus. A bruit may be heard from the turbulent flow in the aneurysm. Unfortunately, however, rupture may be the first hint of AAA. Once an aneurysm has ruptured, it presents with classic symptoms of abdominal pain which is severe, constant, and radiating to the back. The diagnosis of an abdominal Aortic Aneurysm can be confirmed at the bedside by the use of ultrasound. Rupture may be indicated by the presence of free fluid in the abdomen. A contrast-enhanced abdominal CT scan is the best test to diagnose an AAA and guide treatment options. Only 10–25% of patients survive rupture due to large pre- and post-operative mortality. Annual mortality from ruptured aneurysms in the United States is about 15,000. Most are due to abdominal aneurysms, with thoracic and thoracoabdominal aneurysms making up 1% to 4% of the total. An Aortic Aneurysm can rupture from wall weakness. Aortic rupture is a surgical emergency, and has a high mortality even with prompt treatment. Weekend admission for ruptured Aortic Aneurysm is associated with an increased mortality compared with admission on a weekday, and this is likely due to several factors including a delay in prompt surgical intervention.[5] An Aortic Aneurysm can occur as a result of trauma, infection, or, most commonly, from an intrinsic abnormality in the elastin and collagen components of the aortic wall. While definite genetic abnormalities were identified in true genetic syndromes (Marfan, Elher-Danlos and others) associated with Aortic Aneurysms, both thoracic and abdominal Aortic Aneurysms demonstrate a strong genetic component in their aetiology.[6] The risk of aneurysm enlargement may be diminished with attention to the patient's blood pressure, smoking and cholesterol levels. There have been proposals to introduce ultrasound scans as a screening tool for those most at risk: men over the age of 65.[7][8] The tetracycline antibiotic doxycycline is currently being investigated for use as a potential drug in the prevention of Aortic Aneurysm due to its metalloproteinase inhibitor and collagen stabilizing properties. Anacetrapib is a cholesteryl ester transfer protein inhibitor that raises high-density lipoprotein (HDL) cholesterol and reduces low-density lipoprotein (LDL) cholesterol. Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin[9] Elevating the amount of HDL cholesterol in the abdominal area of the aortic artery in mice both reduced the size of aneurysms that had already grown and prevented abdominal Aortic Aneurysms from forming at all. In short, raising HDL cholesterol is beneficial because it induces programmed cell death. The walls of a failing aorta are replaced and strengthened. New lesions should not form at all when using this drug.[10] Screening for an Aortic Aneurysm so that it may be detected and treated prior to rupture is the best way to reduce the overall mortality of the disease. The most cost-efficient screening test is an abdominal aortic ultrasound study. Noting the results of several large, population-based screening trials, the US Centers for Medicare and Medicaid Services (CMS) now provides payment for one ultrasound study in male or female smokers aged 65 years or older ("SAAAVE Act"). Surgery (open or endovascular) is the definite treatment of an Aortic Aneurysm. Medical therapy is typically reserved for smaller aneurysms or for elderly, frail patients where the risks of surgical repair exceed the risks of non-operative therapy (observation alone). Medical therapy of Aortic Aneurysms involves strict blood pressure control. This does not treat the Aortic Aneurysm per se, but control of hypertension within tight blood pressure parameters may decrease the rate of expansion of the aneurysm. The medical management of patients with Aortic Aneurysms, reserved for smaller aneurysms or frail patients, involves cessation of smoking, blood pressure control, use of statins and occasionally beta blockers. Ultrasound studies are obtained on a regular basis (i.e. every six or 12 months) to follow the size of the aneurysm. Decisions about repairing an Aortic Aneurysm are based on the balance between the risk of aneurysm rupture without treatment versus the risks of the treatment itself. For example, a small aneurysm in an elderly patient with severe cardiovascular disease would not be repaired. The chance of the small aneurysm rupturing is overshadowed by the risk of cardiac complications from the procedure to repair the aneurysm. The risk of the repair procedure is two-fold. First, there is consideration of the risk of problems occurring during and immediately after the procedure itself ("peri-procedural" complications). Second, the effectiveness of the procedure must be taken into account, namely whether the procedure effectively protects the patient from aneurysm rupture over the long-term, and whether the procedure is durable so that secondary procedures, with their attendant risks, are not necessary over the life of the patient. These issues attain importance and should be considered when making a choice between different treatment options. A less invasive procedure (such as endovascular aneurysm repair) may be associated with fewer short-term risks to the patient (fewer peri-procedural complications) but secondary procedures may be necessary over long-term follow-up. The definitive treatment for an Aortic Aneurysm may be surgical or endovascular repair. The determination of surgical intervention is complex and determined on a per-case basis. Risk of aneurysm rupture is weighed against procedural risk. The diameter of the aneurysm, its rate of growth, the presence or absence of Marfan syndrome, Ehlers–Danlos syndromes or similar connective tissue disorders, and other co-morbidities are all important factors in the overall treatment. A rapidly expanding aneurysm should under normal circumstances be operated on as soon as feasible, as it has a greater chance of rupture. Slowly expanding Aortic Aneurysms may be followed by routine diagnostic testing (i.e.: CT scan or ultrasound imaging). For abdominal aneurysms, the current treatment guidelines for abdominal Aortic Aneurysms suggest elective surgical repair when the diameter of the aneurysm is greater than 5 cm (2 in). However, recent data on patients aged 60–76 suggest medical management for abdominal aneurysms with a diameter of less than 5.5 cm (2 in).[11] Open surgery starts with exposure of the dilated portion of the aorta via an incision in the abdomen or abdomen and check, followed by insertion of a synthetic (Dacron or Gore-Tex) graft (tube) to replace the diseased aorta. The graft is sewn in by hand to the non-diseased portions of the aorta, and the aneurysmal sac is closed around the graft. The aorta and its branching arteries are cross-clamped during open surgery. This can lead to inadequate blood supply to the spinal cord, resulting in paraplegia. A 2004 systematic review and meta analysis found that cerebrospinal fluid drainage (CFSD), when performed in experienced centers, reduces the risk of ischemic spinal cord injury by increasing the perfusion pressure to the spinal cord.[12] A 2012 Cochrane systematic review noted that further research regarding the effectiveness of CFSD for preventing a spinal cord injury is required.[13] Endovascular treatment of Aortic Aneurysms is a minimally invasive alternative to open surgery repair. It involves placement of an endo-vascular stent through small incisions at the top of each leg into the aorta. As compared to open surgery, EVAR has a lower risk of death in the short term and a shorter hospital stay but may not always be an option.[2][14][15] There does not appear to be a difference in longer term outcomes between the two.[16] After EVAR, repeat procedures are more likely to be needed.[17] Better results are only in uncomplicated, elective descending thoracic and infrarenal aorta. Moreover, recent USA data from 2006–2007 of isolated descending thoracic aorta aneurysms found 23% of ideal candidate (uncomplicated, elective descending Aortic Aneurysms) underwent to TEVAR, the remaining 77% underwent open surgical repair.[18] Aortic Aneurysms resulted in about 152,000 deaths in 2013 up from 100,000 in 1990.[4] Although rare, intravascular coagulation in thoracic and abdominal Aortic Aneurysms could occur as firstly reported by Fine et al. Typically related to disseminated intravascular coagulation (DIC), aneurysm-induced DIC was reported in the literature. As DIC progresses, the consumption of the coagulation factors increases and leads to an increase in clotting time and excessive bleeding. In addition to chronic bleeding disorder and a consumptive coagulopathy, the aneurysm-induced DIC should return and maintain normal coagulation characteristics after aneurysm  repair  as suggested  by  Siebert and  Natelson.  Due to the abnormalities on blood clotting and excessive bleeding, DIC was suggested to be treated with an anticoagulant such as heparin prior to the aneurysm repair. However, contradicting findings on the use of heparin to treat DIC were summarized in the literature. An in-depth and accurate method on the assessment of blood coagulation and blood clot formation would further assist in the screening of DIC for preoperative treatment since only 4% (three out of 76) of the Aortic Aneurysm patients revealed their clinical relevance. Blood coagulation and thrombus formation also occur during the EVAR and aortic dissection. With thrombocytopenia as a potential risk factor for EVAR, Nienaber et al. reported the development of DIC due to endovascular leakage. On the other hand, EVAR was shown to enhance thrombin activation comparing with open surgical repair, potentially due to the contact between blood and endovascular stent graft materials. The blood coagulation and partial thrombus formation in the false lumen of an aortic dissection also played a critical role in the patients' mortality rate and aneurysm growth.

Source:Wikipedia.org